Update on current TAVI technology, indications, screening, and outcomes
Continuing Cardiology Education · 2016
DOI: 10.1002/cce2.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Continuing Cardiology Education, 2016. Verfasst von A. Halapas und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Transcatheter aortic valve replacement ( TAVI ) is an established treatment for inoperable patients or patients at high surgical risk with severe aortic stenosis. Herein, we illustrate the key design features of the main new generation devices that are entering contemporary clinical practice, the labeled and off‐labeled indications, the basic principles of screening process, and the clinical outcomes of the TAVI procedure. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193543/Activity.aspx
Zitieren
APA
Halapas, A., Chrissoheris, M., Bouboulis, N., Nicolaou, J., Pattakos, S., & Spargias, K. (2016). Update on current TAVI technology, indications, screening, and outcomes. Continuing Cardiology Education. https://doi.org/10.1002/cce2.20
Vancouver
Halapas A, Chrissoheris M, Bouboulis N, Nicolaou J, Pattakos S, Spargias K. Update on current TAVI technology, indications, screening, and outcomes. Continuing Cardiology Education. 2016. doi:10.1002/cce2.20
BibTeX
@article{Halapas2016,
author = {Halapas, A. and Chrissoheris, M. and Bouboulis, N. and Nicolaou, J. and Pattakos, S. and Spargias, K.},
title = {Update on current TAVI technology, indications, screening, and outcomes},
journal = {Continuing Cardiology Education},
year = {2016},
doi = {10.1002/cce2.20}
}
EUVIMED